Mirum Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares in Public Offering of Common StockBusiness Wire • 08/12/22
Mirum Pharmaceuticals Announces Commencement of Public Offering of Common StockBusiness Wire • 08/09/22
Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/07/22
Mirum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business UpdateBusiness Wire • 08/04/22
Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022Business Wire • 07/28/22
Mirum Pharmaceuticals Highlights Data Demonstrating Impact of LIVMARLI® (maralixibat) on Patients with Alagille Syndrome at European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Annual MeetingBusiness Wire • 06/24/22
Mirum Pharmaceuticals Presents New Data at The International Liver Congress™ of the European Association for the Study of the Liver (EASL)Business Wire • 06/24/22
Mirum Pharmaceuticals to Showcase LIVMARLI® (maralixibat) Data at EASL and ESPGHAN Annual CongressesBusiness Wire • 06/13/22
Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/07/22
Mirum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business UpdateBusiness Wire • 05/05/22
Mirum Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on May 5, 2022Business Wire • 05/02/22
Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/10/22
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business UpdateBusiness Wire • 03/09/22
Why Earnings Season Could Be Great for Mirum Pharmaceuticals (MIRM)Zacks Investment Research • 03/02/22
Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End Business Results for 2021 and Host Conference Call on March 9, 2022Business Wire • 03/02/22
Mirum Pharmaceuticals to Present at SVB Leerink 11th Annual Global Healthcare ConferenceBusiness Wire • 02/09/22
Mirum Pharmaceuticals Provides Business Update and Highlights Key 2022 Corporate MilestonesBusiness Wire • 01/11/22
Mirum Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022Business Wire • 01/04/22